Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Protalix BioTherapeutics (PLX) Return on Assets (2016 - 2025)

Protalix BioTherapeutics (PLX) has 14 years of Return on Assets data on record, last reported at 0.07% in Q3 2025.

  • For Q3 2025, Return on Assets rose 19.0% year-over-year to 0.07%; the TTM value through Sep 2025 reached 0.07%, up 19.0%, while the annual FY2024 figure was 0.04%, 4.0% down from the prior year.
  • Return on Assets reached 0.07% in Q3 2025 per PLX's latest filing, down from 0.08% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.09% in Q3 2023 and bottomed at 0.26% in Q4 2022.
  • Average Return on Assets over 5 years is 0.07%, with a median of 0.06% recorded in 2022.
  • Peak YoY movement for Return on Assets: soared 32bps in 2023, then dropped -24bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.17% in 2021, then crashed by -50bps to 0.26% in 2022, then surged by 124bps to 0.06% in 2023, then decreased by -28bps to 0.04% in 2024, then surged by 54bps to 0.07% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.07% in Q3 2025, 0.08% in Q2 2025, and 0.05% in Q1 2025.